TASHA JONES: Open Payments
NPI 1386206688 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 9 payments from 7 companies in 2025. Trend: 2023 $1,295 · 2024 $1,107 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $325 |
| Gilead Sciences, Inc. | 1 | $122 |
| Alexion Pharmaceuticals, Inc. | 1 | $90 |
| ABIOMED | 1 | $80 |
| AstraZeneca Pharmaceuticals LP | 1 | $78 |
| Axsome Therapeutics, Inc. | 1 | $71 |
| Stryker Corporation | 1 | $50 |
Products named: REPATHA, Epclusa, ULTOMIRIS, AIRSUPRA, Auvelity.
Industry payments across AL — which companies pay providers there.
